Avenue Therapeutics Inc.

NASDAQ: ATXI · Real-Time Price · USD
0.50
-0.04 (-7.41%)
At close: Aug 11, 2025, 11:48 AM

Avenue Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
3.5M 2.59M 2.6M 4.92M 3.19M 1.78M 161K 1.57M 8.24M 6.71M 217K 890K 1.83M 3.76M 585K 1.12M 1.82M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
n/a 78K n/a n/a n/a 67K 310K n/a n/a 137K 338K n/a n/a n/a n/a n/a n/a
Receivables
n/a n/a n/a n/a n/a n/a 13K 26K 13K n/a n/a n/a n/a 90K 74K n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a 310K n/a n/a n/a n/a n/a n/a -90K n/a n/a n/a
Other Current Assets
92K 78K 28K 69K 116K 67K 328K 69K n/a 137K 338K n/a n/a n/a n/a n/a n/a
Total Current Assets
3.59M 2.67M 2.63M 4.99M 3.31M 1.85M 502K 1.67M 8.45M 6.84M 575K 1M 1.96M 3.96M 688K 1.19M 1.94M
Property-Plant & Equipment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
n/a 78K n/a n/a n/a 67K 310K n/a n/a 137K 338K n/a n/a n/a n/a n/a n/a
Total Assets
3.59M 2.67M 2.63M 4.99M 3.31M 1.85M 502K 1.67M 8.45M 6.84M 575K 1M 1.96M 3.96M 688K 1.19M 1.94M
Account Payables
173K 155K 140K 592K 662K 401K 560K 500K 374K 150K 405K 303K 544K 362K 202K 82K 218K
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
86K 34K 316K 47K 413K 586K 3.3M 5.87M 5.72M 2.61M n/a n/a n/a n/a n/a n/a n/a
Total Current Liabilities
1.26M 816K 973K 1.16M 1.41M 1.2M 5.02M 7.81M 10.6M 3.58M 614K 407K 797K 509K 848K 549K 469K
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a 1.84M 949K 405K 397K 544K 362K n/a n/a n/a
Total Liabilities
1.26M 816K 973K 1.16M 1.41M 1.2M 5.02M 7.81M 10.6M 3.58M 614K 407K 797K 509K 848K 549K 469K
Total Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock
n/a n/a n/a n/a n/a 3K 1K 1K 1K n/a n/a 2K 2K 2K 2K 2K 2K
Retained Earnings
-104.43M -102.58M -101.04M -97.96M -95.27M -90.93M -91.57M -92.09M -88.09M -80.55M -81.13M -80.46M -79.86M -77M -76.09M -75.22M -74.27M
Comprehensive Income
n/a n/a n/a n/a n/a -0.00 n/a -0.00 n/a n/a n/a n/a n/a -0.00 -0.00 n/a n/a
Shareholders Equity
3.51M 2.8M 2.61M 4.76M 2.84M 1.58M -3.65M -5.34M -1.45M 3.9M -39K 598K 1.16M 3.45M -160K 642K 1.48M
Total Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a